Intellia Therapeutics
NTLA
NTLA
302 hedge funds and large institutions have $2.69B invested in Intellia Therapeutics in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 119 increasing their positions, 80 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
18% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 60
29% less capital invested
Capital invested by funds: $3.81B → $2.69B (-$1.11B)
Holders
302
Holding in Top 10
7
Calls
$22.8M
Puts
$11.7M
Top Buyers
| 1 | +$49.5M | |
| 2 | +$41.6M | |
| 3 | +$39.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$37.2M |
| 5 |
Morgan Stanley
New York
|
+$34.5M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$12.6M | |
| 3 | -$12.4M | |
| 4 |
Millennium Management
New York
|
-$9.78M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$8.97M |